Given the early stage of drilling with not much diamond core to go by and no outcrop IDA probably have limited idea what the orientation of dip and plunge of ore shoots are. I agree they could have said this on the JORC table. The cross sections show an "interpreted orientation of the high grade veins." If this is the correct orientation then they are certainly not drilling down the dip. I suspect there is an element of supergene enrichment with a sub-horizontal zone similar to Campfire Bore. Sections 10560 and 10640 hint at this and if true the key intersections on 10640 are close to true width.
They also announced sulphide in vein sets in three different orientations in the second announcement. The core photo shows 3 vein sets. Who knows what orientation the mineralisation is given they state the mineralised zone is fractured. Are there faults displacing ore zones making drawing straight lines on sections a bit of a nonsense? So little data to make any real conclusions other than they have some narrow high grade shoots with grades near surface to over 200m below surface.
Who cares where the gold and the pyrite start and end. They made very clear what the lab assays for this zone were. No one needs to estimate or worry about where gold and pyrite start and end. It is a photo showing gold and that is a good tail of gold in the pan at that. But no guess required as they have the lab results. You publish the photo for effect, the same as all those companies that publish photos of gold in diamond core even though they have lab results.
- Forums
- ASX - By Stock
- IDA
- Ann: Stunning High-Grade Gold Results Continue at Minos Prospect
IDA
indiana resources limited
Add to My Watchlist
1.81%
!
8.5¢

Ann: Stunning High-Grade Gold Results Continue at Minos Prospect, page-36
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.5¢ |
Change
0.002(1.81%) |
Mkt cap ! $54.31M |
Open | High | Low | Value | Volume |
8.3¢ | 8.5¢ | 8.3¢ | $49.33K | 581.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 171249 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 135399 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 86904 | 0.084 |
7 | 192427 | 0.083 |
2 | 207600 | 0.082 |
1 | 6173 | 0.081 |
2 | 140000 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 135399 | 1 |
0.086 | 550000 | 1 |
0.087 | 385040 | 2 |
0.088 | 400000 | 1 |
0.090 | 500000 | 1 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
IDA (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online